261723-32-4

Basic information

• Product Name: (3-bromo-2-fluorophenyl)methanol
• Synonyms: (3-bromo-2-fluorophenyl)methanol;3-Bromo-2-fluorobenzyl alcohol 98%;3-BroMo-2-Fluoro-BenzeneMethanol;1-Bromo-2-fluoro-3-(hydroxymethyl)benzene;3-Bromo-2-fluoro-benzyl alcohal
• CAS NO: 261723-32-4
• Molecular Formula: C₇H₆BrFO
• Molecular Weight: 205.03
• Mol File: 261723-32-4.mol
• Article Data: 13

Chemical Properties

• Melting Point: 36.0 to 40.0 °C
• Boiling Point: 263.232 °C at 760 mmHg
• Flash Point: 112.999 °C
• Appearance: /
• Density: 1.658 g/cm³
• Vapor Pressure: 0.005mmHg at 25°C
• Refractive Index: 1.567
• Storage Temp.: 0-10°C
• PKA: 13.80±0.10(Predicted)
• CAS DataBase Reference: (3-bromo-2-fluorophenyl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (3-bromo-2-fluorophenyl)methanol(261723-32-4)
• EPA Substance Registry System: (3-bromo-2-fluorophenyl)methanol(261723-32-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 261723-32-4(Hazardous Substances Data)

Usage

General Description

(3-bromo-2-fluorophenyl)methanol is a chemical compound with the molecular formula C7H6BrFO. It is a white solid that is soluble in organic solvents and is commonly used as a building block in the synthesis of various organic compounds. The compound is often employed as a reagent in organic chemistry reactions, particularly in the formation of carbon-carbon and carbon-heteroatom bonds. Additionally, the compound has potential applications in pharmaceuticals, agrochemicals, and materials science due to its versatile chemical reactivity and potential for creating new chemical structures. As a result, (3-bromo-2-fluorophenyl)methanol is a valuable chemical tool in the development of new compounds for a variety of industrial and research purposes.

InChI:InChI=1/C7H6BrFO/c8-6-3-1-2-5(4-10)7(6)9/h1-3,10H,4H2

Upstream product

• 161957-56-8 3-bromo-2-fluorobenzoic acid 
• 1072-85-1 o-fluorobromobenzene 
• 149947-15-9 3-bromo-2-fluorobenzaldehyde 
• 206551-41-9 2-fluoro-3-bromobenzoic acid methyl ester 

Downstream Products

• 149947-16-0 1-bromo-3-(bromomethyl)-2-fluorobenzene 
• 447463-24-3 (3-{4-[1-(3-bromo-2-fluoro-benzyloxy)-ethyl]-2-methoxy-5-nitro-phenoxy}-propyl)-carbamic acid tert-butyl ester 
• 786652-60-6 1-bromo-3-(chloromethyl)-2-fluorobenzene 
• 149947-15-9 3-bromo-2-fluorobenzaldehyde 
• 1187822-08-7 {2-Fluoro-3-[2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol 
• 1307255-11-3 1-bromo-2-fluoro-3-(methoxymethyl)benzene 
• 1307255-12-4 C₈H₉FO₂ 
• 1307255-13-5 tert-butyl (3-endo)-3-[2-fluoro-3-(methoxymethyl)phenoxy]-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1255208-31-1 5-bromo-4-fluoro-2-benzofuran-1(3H)-one 
• 1204333-52-7 1-bromo-3-(difluoromethyl)-2-fluorobenzene 
• 1698908-91-6 2-[3-(difluoromethyl)-2-fluorophenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 88430-50-6 beraprost 314d 
• 304876-62-8 C₇H₅BrFNO 
• 1009092-04-9 C₇H₇BrFNO 

Relevant articles and documents

PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE

The present invention provides a compound represented by formula [I] shown below or a pharmaceutically acceptable salt thereof that has an inhibitory effect on 20-HETE producing enzyme. (in formula [I] above, the structure represented by formula [II] below: represents any of the structures represented by formula group [III] below: R1, R2, R3, and R4 independently represent a hydrogen atom, a fluorine atom, methyl, or the like, R5 represents any of the structures represented by formula group [IV]:

PD-1/PD-L1 INHIBITORS

Compounds according to formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.

Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof

The present application relates to novel substituted 1-benzylcycloalkylcarboxylic acid derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases, and to their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular disorders.